These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7195790)

  • 21. Levalbuterol in the treatment of patients with asthma and chronic obstructive lung disease.
    Dalonzo GE
    J Am Osteopath Assoc; 2004 Jul; 104(7):288-93. PubMed ID: 15293593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. beta-Adrenergic blockade with pindolol (LB-46) in mild to moderate asthma.
    Sue DY; Hansen JE; Wasserman K
    Chest; 1981 Nov; 80(5):537-42. PubMed ID: 7297143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Chronic beta-stimulant therapy: a possible etiopathogenic factor for hypertrophic cardiomyopathy].
    Speca G; Core A; Pardi L
    G Ital Cardiol; 1993 Jul; 23(7):723-8. PubMed ID: 8104836
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical pharmacology of the beta-adrenolytic activity of pindolol].
    Hugues FC; Julien D; Munera Y; Heams D; Marche J
    Therapie; 1976; 31(2):179-93. PubMed ID: 7858
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical outcomes and treatment cost comparison of levalbuterol versus albuterol in hospitalized adults with chronic obstructive pulmonary disease or asthma.
    Brunetti L; Poiani G; Dhanaliwala F; Poppiti K; Kang H; Suh DC
    Am J Health Syst Pharm; 2015 Jun; 72(12):1026-35. PubMed ID: 26025994
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Controlled clinical trial of beta-adrenergic blockade in hypertrophic obstructive cardiomyopathy (HOCM).
    Hubner P; Ziady G; Lane G; Pridie R; Scales J
    Br Heart J; 1972 Sep; 34(9):963. PubMed ID: 4403883
    [No Abstract]   [Full Text] [Related]  

  • 27. [Do guide lines for differential therapy in hypertrophic obstructive cardiomyopathy exits?].
    Kaltenbach M; Hopf R; Bussmann WD; Kober G; Petersen Y; Keller M
    Cardiology; 1978; 63 Suppl 1():77-9. PubMed ID: 28845
    [No Abstract]   [Full Text] [Related]  

  • 28. Metabolic and hormonal responses to salbutamol in asthma. Evidence of beta-adrenergic overactivity?
    Kallenbach JM; Panz VR; Jankelow D; Joffe BI; Seftel HC
    Respiration; 1990; 57(1):21-7. PubMed ID: 2163093
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of hypertrophic obstructive cardiomyopathy with verapamil.
    Kaltenbach M; Hopf R; Kober G; Bussmann WD; Keller M; Petersen Y
    Br Heart J; 1979 Jul; 42(1):35-42. PubMed ID: 573129
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-invasive assessment of diastolic function in hypertrophic cardiomyopathy on and off beta adrenergic blocking drugs.
    Alvares RF; Goodwin JF
    Br Heart J; 1982 Sep; 48(3):204-12. PubMed ID: 6125160
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Levalbuterol compared to racemic albuterol: efficacy and outcomes in patients hospitalized with COPD or asthma.
    Truitt T; Witko J; Halpern M
    Chest; 2003 Jan; 123(1):128-35. PubMed ID: 12527613
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect on beta adrenergic receptors of tachyphylaxis on the sensitivity of smooth muscle in the bronchi to beta adrenergic receptor agonists in bronchial asthma].
    Passowicz-Muszyńska E
    Pol Tyg Lek; 1990 Jul 16-30; 45(29-31):608-11. PubMed ID: 1963682
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-acting beta 2-agonist salmeterol compared with albuterol in maintenance asthma therapy.
    Pearlman DS
    Ann Allergy Asthma Immunol; 1995 Aug; 75(2):180-4. PubMed ID: 7648385
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma.
    D'Alonzo GE; Nathan RA; Henochowicz S; Morris RJ; Ratner P; Rennard SI
    JAMA; 1994 May; 271(18):1412-6. PubMed ID: 7909853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lack of adverse cardiac effects of combined treatment with theophylline and albuterol in asthmatic children.
    Bastianon V; Di Fazio A; Colloridi V; Marzano MC; Ferrucci A; Pucci S; Bernardini L; Coletta F; Sorbara N; Businco L
    Ann Allergy; 1990 Sep; 65(3):201-5. PubMed ID: 2403225
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Physiopathological and clinical studies on the use of beta-stimulating drugs].
    Tellini M; D'Ambrosio R
    Minerva Med; 1976 Mar; 67(15):999-1004. PubMed ID: 4754
    [No Abstract]   [Full Text] [Related]  

  • 37. [Comparative clinical study of the bronchomotor effects of practolol and pindolol in chronic obstructive syndromes].
    Bercea O; Duţu S; Jienescu Z; Radu G
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1974; 23(5):451-7. PubMed ID: 4377625
    [No Abstract]   [Full Text] [Related]  

  • 38. Treatment with (R)-albuterol has no advantage over racemic albuterol.
    Barnes PJ
    Am J Respir Crit Care Med; 2006 Nov; 174(9):969-72; discussion 972-4. PubMed ID: 17060668
    [No Abstract]   [Full Text] [Related]  

  • 39. Lack of subsensitivity to albuterol after treatment with salmeterol in patients with asthma.
    Nelson HS; Berkowitz RB; Tinkelman DA; Emmett AH; Rickard KA; Yancey SW
    Am J Respir Crit Care Med; 1999 May; 159(5 Pt 1):1556-61. PubMed ID: 10228126
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of propranolol on response to exercise in hypertrophic obstructive cardiomyopathy.
    Edwards RH; Kristinsson A; Warrell DA; Goodwin JF
    Br Heart J; 1970 Mar; 32(2):219-25. PubMed ID: 5462284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.